Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
The efficacy of monitoring drug safety alerts and implementation of risk evaluation management
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: TSAI, Nien Tzu (Shin Kong Wu Ho-Su Memorial Hospital, Pharmacy Department)
- Co-author(s): Nien Tzu Tsai
BackgroundFifty years ago, Thalidomide was found to be associated with congenital abnormality in children. With more novel drugs marketed, it’s necessary to monitor drug safety alerts at any time to prevent harmful injuries.
MethodsOur plan is monitoring domestic and international drug safety alerts closely, including Food and Drug Administration.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019